Robert T Foster - Net Worth and Insider Trading
Robert T Foster Net Worth
The estimated net worth of Robert T Foster is at least $23,221 dollars as of 2024-12-28. Robert T Foster is the CEO and Director of Hepion Pharmaceuticals Inc and owns about 50,470 shares of Hepion Pharmaceuticals Inc (HEPA) stock worth over $23,221. Details can be seen in Robert T Foster's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Robert T Foster has not made any transactions after 2023-09-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Robert T Foster
Robert T Foster Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Robert T Foster owns 2 companies in total, including Hepion Pharmaceuticals Inc (HEPA) , and Aurinia Pharmaceuticals Inc (AUPH) .
Click here to see the complete history of Robert T Foster’s form 4 insider trades.
Insider Ownership Summary of Robert T Foster
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HEPA | Hepion Pharmaceuticals Inc | 2023-09-18 | Chief Scientific Officer |
| AUPH | Aurinia Pharmaceuticals Inc | 2023-09-21 | director |
Robert T Foster Latest Holdings Summary
Robert T Foster currently owns a total of 1 stock. Robert T Foster owns 50,470 shares of Hepion Pharmaceuticals Inc (HEPA) as of September 18, 2023, with a value of $23,221.
Latest Holdings of Robert T Foster
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HEPA | Hepion Pharmaceuticals Inc | 2023-09-18 | 50,470 | 0.46 | 23,221 |
Holding Weightings of Robert T Foster
Robert T Foster Form 4 Trading Tracker
According to the SEC Form 4 filings, Robert T Foster has made a total of 4 transactions in Hepion Pharmaceuticals Inc (HEPA) over the past 5 years, including 4 buys and 0 sells. The most-recent trade in Hepion Pharmaceuticals Inc is the acquisition of 1,600 shares on September 18, 2023, which cost Robert T Foster around $8,960.
Insider Trading History of Robert T Foster
- 1
Robert T Foster Trading Performance
GuruFocus tracks the stock performance after each of Robert T Foster's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Robert T Foster is -19.37%. GuruFocus also compares Robert T Foster's trading performance to market benchmark return within the same time period. The performance of stocks bought by Robert T Foster within 3 months outperforms 1 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Robert T Foster's insider trading performs compared to the benchmark.
Performance of Robert T Foster
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -2.72 | | | | | |
| Relative Return to S&P 500(%) | -2.09 | | | | | |
Robert T Foster Ownership Network
Robert T Foster Owned Company Details
What does Hepion Pharmaceuticals Inc do?
Who are the key executives at Hepion Pharmaceuticals Inc?
Robert T Foster is the Chief Scientific Officer of Hepion Pharmaceuticals Inc. Other key executives at Hepion Pharmaceuticals Inc include Chief Financial Officer John T Cavan , director & CEO and President Gary S Jacob , and 10 percent owner Donald E Garlikov .
Hepion Pharmaceuticals Inc (HEPA) Insider Trades Summary
Over the past 18 months, Robert T Foster made 2 insider transaction in Hepion Pharmaceuticals Inc (HEPA) with a net purchase of 3,200. Other recent insider transactions involving Hepion Pharmaceuticals Inc (HEPA) include a net purchase of 8,000 shares made by Peter Wijngaard ,
In summary, during the past 3 months, insiders sold 0 shares of Hepion Pharmaceuticals Inc (HEPA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Hepion Pharmaceuticals Inc (HEPA) were sold and 11,200 shares were bought by its insiders, resulting in a net purchase of 11,200 shares.
Hepion Pharmaceuticals Inc (HEPA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Hepion Pharmaceuticals Inc Insider Transactions
Robert T Foster Mailing Address
Above is the net worth, insider trading, and ownership report for Robert T Foster. You might contact Robert T Foster via mailing address: C/o Contravir Pharmaceuticals, Inc., 399 Thornall Street, First Floor, Edison Nj 08837.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
